Immune Factors and Recurrent Abortion: A Review
1983; Wiley; Volume: 4; Issue: 4 Linguagem: Inglês
10.1111/j.1600-0897.1983.tb00274.x
ISSN2374-8184
Autores Tópico(s)Xenotransplantation and immune response
ResumoAmerican Journal of Reproductive ImmunologyVolume 4, Issue 4 p. 179-181 Immune Factors and Recurrent Abortion: A Review C.W.G. Redman, Corresponding Author C.W.G. Redman Nuffield Department of Obstetrics and Gynaecology John Radcliffe Hospital Headington, Oxford, EnglandNuffield Department of Obstetrics and Gynaecology John Radcliffe Hospital, Headington, Oxford OX3 9DU, England.Search for more papers by this author C.W.G. Redman, Corresponding Author C.W.G. Redman Nuffield Department of Obstetrics and Gynaecology John Radcliffe Hospital Headington, Oxford, EnglandNuffield Department of Obstetrics and Gynaecology John Radcliffe Hospital, Headington, Oxford OX3 9DU, England.Search for more papers by this author First published: December 1983 https://doi.org/10.1111/j.1600-0897.1983.tb00274.xCitations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Gill TJ. Immunogenetics of spontaneous abortions in humans. Transplantation 1983; 35: 1–6. 10.1097/00007890-198301000-00001 PubMedWeb of Science®Google Scholar 2 Billington WD. Influence of immunological dissimilarity of mother and fetus in size of placenta in mice. Nature. 1964; 202: 317–318. 10.1038/202317a0 PubMedWeb of Science®Google Scholar 3 James DA. Some effects of immunological factors on gestation in mice. J Reprod Fertil. 1967; 14: 265–275. 10.1530/jrf.0.0140265 PubMedWeb of Science®Google Scholar 4 Beer AE, Scott JR, Billingham RE. Histoincompatibility and maternal immunological status as determinants of fetoplacental weight and litter size of rodents. J Exp Med. 1975; 142: 180–196. 10.1084/jem.142.1.180 CASPubMedWeb of Science®Google Scholar 5 Finkel SI, Lilly F. Influence of histoincompatibility between mother and fetus on placental size in mice. Nature. 1971; 234: 102–103. 10.1038/234102a0 CASPubMedWeb of Science®Google Scholar 6 Hetherington CM, Humber DP, Clarke AG. Genetic and immunologic aspects of litter size in the mouse. J Immunogenet. 1976; 3: 245–252. 10.1111/j.1744-313X.1976.tb00581.x CASPubMedWeb of Science®Google Scholar 7 Auerbach R, Hay JB, Kubai L. Feto-maternal histoincompatibility and placental blood flow. J Physiol (Lond). 1980; 307: 465–74. 10.1113/jphysiol.1980.sp013447 CASPubMedWeb of Science®Google Scholar 8 Newell CA, Bias WB, Hopkins KA. HLA and reproductive outcome in the Amish. Am J Reprod Immunol. 1983; 3: 195. Web of Science®Google Scholar 9 St. Hill CA, Finn R, Denye V. Depression of cellular immunity in pregnancy due to a serum factor. Br Med J. 1973; 3: 513–514. 10.1136/bmj.3.5879.513 CASPubMedWeb of Science®Google Scholar 10 Petrucco OM, Seamark RF, Holmes K, Forbes IJ, Symons RG. Changes in lymphocyte function during pregnancy. Br J Obstet Gynaecol. 1976; 83: 245–250. 10.1111/j.1471-0528.1976.tb00818.x CASPubMedWeb of Science®Google Scholar 11 Griffin JFT, Beck I. A longitudinal study of leucocyte numbers and mitogenesis during the last ten weeks of human pregnancy. J Reprod Immunol. 1983; 5: 239–247. 10.1016/0165-0378(83)90239-5 PubMedWeb of Science®Google Scholar 12 Lawler SD, Dewar PJ, Mrazek I, Jones EH, Hockley AB. Antisera with Ia specificity selected by lymphocytes from patients with chronic lymphocytic leukaemia. Vox Sanguinis. 1978; 34: 200–207. 10.1111/j.1423-0410.1978.tb02468.x CASPubMedWeb of Science®Google Scholar 13 Decary F, Van Helden-Henningheim L, Van Griethuysen D, Helmerhorst FM, Van Der Werf AJM, Engelfriet CP. Detection of Bcell-specific alloantibodies in pregnancy sera in the lymphocytotoxicity and the indirect immunofluorescence techniques. Tissue Antigen. 1979; 14: 1–9. 10.1111/j.1399-0039.1979.tb00814.x CASPubMedWeb of Science®Google Scholar 14 Curtoni ES, Pellegrino MA, Indiveri E, Borelli I, Ferrone S. Persistence of cytotoxic antibodies to HLA-A,B,C antigens and to Ia-like antigens in parous women. J Immunogenet. 1981; 8: 281–285. 10.1111/j.1744-313X.1981.tb00770.x CASPubMedWeb of Science®Google Scholar 15 Albrechtsen D, Solheim BG, Thorsby E. Antiserum inhibition of the mixed lymphocyte culture (MLC) interaction. Inhibitory effect of antibodies reactive with HLA-D associated determinants. Cell Immunol. 1977; 28: 258–273. 10.1016/0008-8749(77)90110-1 PubMedWeb of Science®Google Scholar 16 Jonker M, De Rooy-Doyer L. Possible mechanisms by which alioantisera inhibit in the MLC test. Tissue Antigens. 1980; 15: 1–10. 10.1111/j.1399-0039.1980.tb00878.x CASPubMedWeb of Science®Google Scholar 17 Greenberg LJ, Reinsmoen N, Yunis EJ. Dissociation of stimulation (MLR-S) and response (MLR-R) in mixed leukocyte culture by serum blocking factors. Transplantation. 1973; 16: 520–522. 10.1097/00007890-197311000-00019 Web of Science®Google Scholar 18 Robert M, Betuel H, Revillard JP. Inhibition of the mixed lymphocyte reaction by sera from multipara. Tissue Antigens. 1973; 3: 39–56. 10.1111/j.1399-0039.1973.tb00976.x PubMedWeb of Science®Google Scholar 19 Brochier J, Roitt IM, Festenstein H. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera. Eur J Immunol. 1974; 4: 709–715. 10.1002/eji.1830041102 CASPubMedWeb of Science®Google Scholar 20 Bissenden JG, Ling NR, Mackintosh P. Suppression of mixed lymphocyte reactions by pregnancy serum. Clin Exp Immunol. 1980; 39: 195–202. CASPubMedWeb of Science®Google Scholar 21 Doughty RW, Gelsthorpe K. Some parameters of lymphocyte antibody activity through pregnancy and further eluates of placental material. Tissue Antigens. 1976; 8: 43–48. 10.1111/j.1399-0039.1976.tb00550.x CASPubMedWeb of Science®Google Scholar 22 Faulk WP, Jeannet M, Creighton WD, Carbonara A. Immunological studies of the human placenta. J Clin Invest. 1974; 54: 1011–1019. 10.1172/JCI107844 CASPubMedWeb of Science®Google Scholar 23 Jeannet M, Werner C, Ramirez E, Vassalli P, Faulk WP. Anti-HLA, anti-human "la-like" and MLC blocking activity of human placental IgG. Transplant Proc. 1977; 9: 1417–1422. CASPubMedWeb of Science®Google Scholar 24 Jonker M, Van Leeuwen A, Van Rood JJ. Inhibition of the mixed leukocyte reaction by alloantisera in man. II Incidence and characteristics of MLC-inhibitory antisera from muciparous women. Tissue Antigens. 1977; 9: 246–258. 10.1111/j.1399-0039.1977.tb01115.x CASPubMedWeb of Science®Google Scholar 25 Rocklin RE, Kitzmiller JL, Carpenter CB, Garovoy MR, David JR. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med. 1976; 295: 1209–1213. 10.1056/NEJM197611252952201 CASPubMedWeb of Science®Google Scholar 26 Stimson WH, Strachan AF, Shepherd A. Studies on the maternal immune response to placental antigens: Absence of a blocking factor from the blood of abortion-prone women. Br J Obstet Gynaecol. 1979; 86: 41–45. 10.1111/j.1471-0528.1979.tb10682.x CASPubMedWeb of Science®Google Scholar 27 Power DA, Catto GRD, Mason RJ, Macleod AM, Stewart GM, Stewart KN, Shewan WG. The fetus as an allograft: Evidence for protective antibodies to HLA-linked paternal antigens. Lancet. 1983; 2: 701–704. 10.1016/S0140-6736(83)92246-8 CASPubMedWeb of Science®Google Scholar 28 Sarmay G, Sanderson A, Ivanyi J. Modulation of Fc receptors on human peripheral blood lymphocytes by antisera against β2 microglobulin, Ia or immunoglobulin. Immunology. 1979; 36: 339–344. CASPubMedWeb of Science®Google Scholar 29 Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW. Antiidiotypc antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA. 1983; 80: 830–834. 10.1073/pnas.80.3.830 PubMedWeb of Science®Google Scholar 30 Faulk WP, Temple A, Lovins RE, Smith N. Antigens of human trophoblasts: A working hypothesis for their role in normal and abnormal pregnancies. Proc Natl Acad Sci USA. 1978; 75: 1947–1951. 10.1073/pnas.75.4.1947 CASPubMedWeb of Science®Google Scholar 31 Hamilton TA, Wada HG, Sussman HH. Expression of human placental cell surface antigens on peripheral blood lymphocytes and lymphoblastoid cell lines. Scand J Immunol. 1980; 11: 195–201. 10.1111/j.1365-3083.1980.tb00227.x CASPubMedWeb of Science®Google Scholar 32 Johnson PM, Cheng HM, Molloy CM, Stern CMM, Slade MB. Human trophoblast-specific surface antigens identified using monoclonal antibodies. Am J Reprod Immunol. 1981; 2: 246–254. 10.1111/j.1600-0897.1981.tb00049.x Google Scholar 33 McIntyre JA, Faulk WP. Trophoblast modulation of maternal allogeneic recognition. Proc Natl Acad Sci USA. 1979; 76: 4029–4032. 10.1073/pnas.76.8.4029 CASPubMedWeb of Science®Google Scholar 34 Bresnihan B, Grigor RR, Oliver M, Lewkonia RM, Hughes GRV, Lovins RE, Faulk WP. Immunological mechanism for spontaneous abortion in systemic lupus erythematosus. Lancet. 1977; ii: 1205–1207. 10.1016/S0140-6736(77)90441-X Google Scholar 35 Brown PJ, Johnson PM. Fcγ-receptor activity of isolated human placental syncytiotrophoblast plasma membrane. Immunology. 1981; 42: 313–319. CASPubMedWeb of Science®Google Scholar 36 Taylor C, Faulk WP. Prevention of recurrent abortion with leucocyte transfusions. Lancet. 1981; i: 68–70. 10.1016/S0140-6736(81)90413-X Google Scholar 37 McIntyre JA, Faulk WP. Maternal blocking factors in human pregnancy are found in plasma not serum. Lancet. 1979; ii: 821–823. 10.1016/S0140-6736(79)92176-7 Google Scholar 38 Opelz G, Terasaki PI. International study of histocompatibility in renal transplantation. Transplantation. 1982; 33: 87–95. 10.1097/00007890-198201000-00017 CASPubMedWeb of Science®Google Scholar 39 Lenhard V, Massen G, Seifert P, Johannsen R, Grosse-Wilde H. Characterisation of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc. 1982; 14: 329–332. CASPubMedWeb of Science®Google Scholar 40 Klatzmann D, Gluckman JC, Foucault C, Duboust A, Bensussan A, Assogba J, Berthelot JM. Modification of mixed lymphocyte reactivity after blood transfusion in man. Transplant Proc. 1983; 15: 1016–1018. Web of Science®Google Scholar 41 Lenhard V, Maassen G, Grosse-Wilde H, Wernet P, Opelz G. Effect of blood transfusions on immunoregulatory mononuclear cells in prospective transplant recipients. Transplant Proc. 1983; 15: 1011–1015. Web of Science®Google Scholar 42 MacLeod AM, Mason RJ, Stewart KN, Power DA, Shewan WG, Edward N, Catto GRD. Fc-receptor-blocking antibodies develop after blood transfusions and correlate with good graft outcome. Transplant Proc. 1983; 15: 1019–1021. Web of Science®Google Scholar 43 Singal DP, Fagnilli L, Joseph S. Blood transfusions induce antiidiotypc antibodies in renal transplant patients. Transplant Proc. 1983; 15: 1005–1008. Web of Science®Google Scholar 44 Woodruff MFA, Van Rood JJ. Possible implications of the effect of blood transfusion on allograft survival. Lancet. 1983; i: 1201–1202. 10.1016/S0140-6736(83)92476-5 Google Scholar 45 Francis DMA, Shenton BK. Blood transfusion and tumour-growth: Evidence from laboratory animals. Lancet. 1981; ii: 871. 10.1016/S0140-6736(81)91133-8 Google Scholar 46 Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet. 1982; ii: 662. 10.1016/S0140-6736(82)92764-7 Google Scholar 47 Beck I, Scott JS, Pepper M, Speck EH. The effect of neonatal exchange and later blood transfusions on lymphocyte cultures. Am J Reprod Immunol. 1981; 1: 224–225. 10.1111/j.1600-0897.1981.tb00043.x Web of Science®Google Scholar 48 Desai RG, Creger WP. Maternofetal passage of leukocytes and platelets in man. J Haematol. 1963; 21: 665–673. CASPubMedWeb of Science®Google Scholar 49 Rigby PG, Hanson T, Smith R. Passage of leukemia cells across the placenta. N Engl J Med. 1964; 271: 124–127. 10.1056/NEJM196407162710304 CASPubMedWeb of Science®Google Scholar 50 Beer AE, Billingham RE. Procurement of runt disease of maternal origin. Transplant Proc. 1973; 5: 887–891. CASPubMedWeb of Science®Google Scholar 51 Palm J. Maternal-fetal histocompatibility in rats: An escape from adversity. Cancer Res. 1974; 34: 2061–2065. CASPubMedWeb of Science®Google Scholar 52 Kadowaki J, Thompson RI, Zuelzer WW, Woolley PV, Brough AJ, Gruber D. XX/XY lymphoid chimaerism in congenital immunological deficiency syndrome with thymic alymphoplasia. Lancet. 1965; ii: 1152–1156. 10.1016/S0140-6736(65)92559-6 CASGoogle Scholar 53 Grogan JM, Broughton DD, Doyle WF. Graft versus-host reaction (GVHR). A case report suggesting GVHR occurred as a result of materno-fetal cell transfer. Arch Pathol. 1975; 99: 330–334. CASPubMedWeb of Science®Google Scholar 54 Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O'Reilly RJ. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft versus host disease. Transplantation. 1980; 30: 331–334. 10.1097/00007890-198011000-00004 CASPubMedWeb of Science®Google Scholar 55 Hurtenbach U, Sachs DH, Shearer GM. Protection against graft versus host-associated immunosuppression in F1 mice. J Exp Med. 1981; 154: 1922–1934. 10.1084/jem.154.6.1922 CASPubMedWeb of Science®Google Scholar 56 Hansen JA, Good RA, Dupont B, HLA-D compatibility between parent and child. Transplantation. 1977; 23: 366–374. 10.1097/00007890-197704000-00011 CASPubMedWeb of Science®Google Scholar 57 Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification by HLA-typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982; 307: 662–666. 10.1056/NEJM198209093071106 PubMedWeb of Science®Google Scholar 58 Werner-Favre CH, Jeannet M. HLA compatibility in couples with children suffering from acute leukemia or aplastic anaemia. Tissue Antigens. 1979; 13: 307–309. 10.1111/j.1399-0039.1979.tb00799.x CASPubMedWeb of Science®Google Scholar 59 Artzt K. The T/t complex: A family of genes controlling early embryonic surface antigens. In: Fetal Antigens and Cancer. Ciba Foundation Symposium 96, Pitman, London 1983; 55–68. Web of Science®Google Scholar 60 Awdeh ZL, Raum D, Yunis EJ, Alper CA. Extended HLA/complement allelic haplotypes: Evidence for T/t-like complex in man. Proc Natl Acad Sci USA. 1983; 80: 259–263. 10.1073/pnas.80.1.259 CASPubMedWeb of Science®Google Scholar Citing Literature Volume4, Issue4December 1983Pages 179-181 ReferencesRelatedInformation
Referência(s)